Clinical Trial of WBC100 on Advanced Solid Tumor

NCT05100251 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

68

Enrollment

OTHER

Sponsor class

Stopped sponsor's decision to change development strategy (the QOD cohort was completed).

Conditions

Solid Tumor

Interventions

DRUG: WBC100 QOD
DRUG: WBC100 QD
DRUG: WBC100 BID

Sponsor

Zhejiang University

Collaborators

[object Object]